These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 19028383)
1. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome. Chan TF; Tsai YC; Chiu PR; Chen YL; Lee CH; Tsai EM Fertil Steril; 2010 Feb; 93(3):869-73. PubMed ID: 19028383 [TBL] [Abstract][Full Text] [Related]
2. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743 [TBL] [Abstract][Full Text] [Related]
3. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849 [TBL] [Abstract][Full Text] [Related]
4. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA; Shin SY; Yoon BK; Choi D Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414 [TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
6. The relationship between retinol-binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome. Mellati AA; Sharifi F; Sajadinejad M; Sohrabi D; Mazloomzadeh S Scand J Clin Lab Invest; 2012 Feb; 72(1):39-44. PubMed ID: 22023042 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763 [TBL] [Abstract][Full Text] [Related]
8. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
9. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560 [TBL] [Abstract][Full Text] [Related]
10. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Lee DC; Lee JW; Im JA Metabolism; 2007 Mar; 56(3):327-31. PubMed ID: 17292720 [TBL] [Abstract][Full Text] [Related]
11. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [TBL] [Abstract][Full Text] [Related]
12. Serum resistin levels in women with polycystic ovary syndrome. Panidis D; Koliakos G; Kourtis A; Farmakiotis D; Mouslech T; Rousso D Fertil Steril; 2004 Feb; 81(2):361-6. PubMed ID: 14967374 [TBL] [Abstract][Full Text] [Related]
13. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145 [TBL] [Abstract][Full Text] [Related]
14. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome. Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993 [TBL] [Abstract][Full Text] [Related]
15. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Chan TF; Chen YL; Chen HH; Lee CH; Jong SB; Tsai EM Fertil Steril; 2007 Aug; 88(2):401-5. PubMed ID: 17335820 [TBL] [Abstract][Full Text] [Related]
16. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
17. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases]. Song J; Shen H; Li J; Huang Z; Zhang Y Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071 [TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease. Oktem M; Ozcimen EE; Uckuyu A; Esinler I; Pamuk B; Bayraktar N; Kulaksizoglu S; Zeyneloglu HB Fertil Steril; 2009 Jun; 91(6):2545-50. PubMed ID: 18554599 [TBL] [Abstract][Full Text] [Related]
20. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]